Clinical Ink, Inc. — Form D/A

Clinical Ink, Inc. of Winston-Salem, NC, a company, filed a Form D amendment with the SEC on 2015-04-07. The offering totals $9.9M, of which $9.9M was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Todd RS FoleyDirectorBoston, MA
Ansbert RS GadickeDirectorBoston, MA
Brad RS GeesamanDirectorBoston, MA
Morana RS Jovan-EmbiricosDirectorLondon, X0
Matt RS KingDirectorBrentwood, TN
Robert RS KniejskiDirectorWinston-Salem, NC
Edward S SeguineDirectorWinston-Salem, NC
Philip RS Waugh, Jr.DirectorWinston-Salem, NC
Joe RS SchmidtExecutive OfficerWinston-Salem, NC
Edward S SeguineExecutive OfficerWinston-Salem, NC
Edward S SeguinePromoterWinston-Salem, NC
Matthew LaVern KingDirectorWinston-Salem, NC
Richard LaVern MalcolmDirectorWinston-Salem, NC
Roger LaVern DavenportDirectorWinston-Salem, NC
Michael LaVern SorensenDirectorWinston-Salem, NC
Tony S RosenbergDirectorWinston-Salem, NC
Phil S WaughDirectorWinston, Salem, NC
Todd S FoleyDirectorWinston-Salem, NC
Richard S MalcolmDirectorWinston-Salem, NC
Scott S MiltenbergerExecutive OfficerWinston-Salem, NC
Matt S KingDirectorWinston-Salem, NC
Stephen H ColtrinDirectorYardley, PA
Robert H KniejskiDirectorPfafftown, NC
Michael E LesterDirectorBellevue, WA
Edward S Seguine, Jr.DirectorFurlong, PA

Other filings by this issuer (6)

FiledFormOfferingSold
2018-05-18D$5.3M
2017-12-28D$2.5M$1.7M
2015-04-02D$9.9M$9.9M
2013-10-29D$4.3M$1.3M
2011-12-08D$3.5M$3.1M
2010-07-14D$1.0M$400K

More